Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Matthieu Gassiot

1PUBLICATIONS

10CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Jul 24, 2021

PXR Modulates the Prostate Cancer Cell Response to Afatinib by Regulating the Expression of the Monocarboxylate Transporter SLC16A1.

Alice Matheux, Matthieu Gassiot, Gaëlle Fromont

Pageof 1

Frequent Collaborators

1 joint publications

Gaëlle Fromont

1 joint publications

Fanny Leenhardt

1 joint publications

Abdelhay Boulahtouf

1 joint publications

Eric Fabbrizio

1 joint publications

Aurélie Garcin

1 joint publications

Alexandre Evrard

1 joint publications

Nadine Houédé

1 joint publications

Patrick Balaguer

1 joint publications

Céline Gongora

1 joint publications

Philippe Pourquier

Frequent Collaborators

1 joint publications

Gaëlle Fromont

1 joint publications

Fanny Leenhardt

1 joint publications

Abdelhay Boulahtouf

1 joint publications

Eric Fabbrizio

Top Related Videos

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

See more related videos

Top Related Videos

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

See more related videos